Activation of primary porcine endothelial cells induces release of porcine endogenous retroviruses

Transplantation

Volumn 77, Issue 7, 2004, Pages 1071-1079

  Cunningham, Deirdre A ^a   Dos Santos Cruz, Gabriella J ^b   Fernández Suárez, Xosé M ^c   Whittam, Alison J ^d   Herring, Christopher ^e   Copeman, Laura ^f   Richards, Andrew ^e   Langford, Gillian A ^g  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b Pharmagene Laboratories Ltd   (United Kingdom)

^c Visible Genetics United Kingdom   (United Kingdom)

^d IceniBioDiscovery Inc   (United Kingdom)

^e NOVARTIS PHARMA AG   (Switzerland)

^f ROBARTS RESEARCH INSTITUTE   (Canada)

^g Ark Therapeutics Group plc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; SWINE; TRANSGENIC ANIMAL; VIRUS INFECTIVITY; VIRUS TITRATION; XENOTRANSPLANTATION;

ANIMALS; ANTIGENS, CD55; CELLS, CULTURED; ENDOGENOUS RETROVIRUSES; ENDOTHELIAL CELLS; HUMANS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; POLYMERASE CHAIN REACTION; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1942471983     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000114966.20491.50     Document Type: Article

References (52)

1. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282.
2. Le Tissier P, Stoye JP, Takeuchi Y, et al. Two sets of human-tropic pig retrovirus. Nature 1997; 389: 681.
3. Löwer R, Löwer J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A 1996; 93: 5177.
4. Reeves RH, O'Brien SJ. Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences. J Virol 1984; 52: 164.
5. Soe LH, Shimizu RW, Landolph JR, et al. Molecular analysis of several classes of endogenous feline leukemia virus elements. J Virol 1985; 56: 701.
6. Akiyoshi DE, Denaro M, Zhu H, et al. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72: 4503.
7. Jin H, Inoshima Y, Wu D, et al. Expression of porcine endogenous retrovirus in peripheral blood leukocytes from ten different breeds. Transpl Infect Dis 2000; 2: 11.
8. Bosch S, Arnauld C, Jestin A. Study of full-length porcine endogenous retrovirus genomes with envelope gene polymorphism in a specific-pathogen-free Large White swine herd. J Virol 2000; 74: 8575.
9. Herring C, Quinn G, Bower R, et al. Mapping full-length porcine endogenous retroviruses in a large white pig. J Virol 2001; 75: 12252.
10. Fietze E, Prosch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation 1994; 58: 675.
11. Geist LJ, Hopkins HA, Dai LY, et al. Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-alpha promoter. Am J Respir Cell Mol Biol 1997; 16: 31.
12. Katsumata K, Ikeda H, Sato M, et al. Tissue-specific high-level expression ofhuman endogenous retrovirus-R in the human adrenal cortex. Pathobiology 1998; 66: 209.
13. Krieg AM, Gourley MF, Klinman DM, et al. Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 1992; 8: 1991.
14. Larsson E, Venables P, Andersson AC, et al. Tissue and differentiation specific expression on the endogenous retrovirus ERV3 (HERV-R) in normal human tissues and during induced monocytic differentiation in the U-937 cell line. Leukemia 1997; 11(Suppl 3): 142-144.
15. Takeuchi K, Katsumata K, Ikeda H, et al. Expression of endogenous retroviruses, ERV3 and lambda 4-1, in synovial tissues from patients with rheumatoid arthritis. Clin Exp Immunol 1995; 99: 338.
16. Taylor PM, Rose ML, Yacoub MH, et al. Induction of vascular adhesion molecules during rejection ofhuman cardiac allografts. Transplantation 1992; 54: 451.
17. Auchincloss HJ, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433-470.
18. Collins T, Lapierre LA, Fiers W, et al. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci U S A 1986; 83: 446.
19. Leeuwenberg JF, Van Damme J, Meager T, et al. Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur J Immunol 1988; 18: 1469.
20. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988; 107: 321.
21. Batten P, Yacoub MH, Rose ML. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Immunology 1996; 87: 127.
22. Franchin G, Zybarth G, Dai WW, et al. Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J Immunol 2000; 164: 2592.
23. Lane BR, Markovitz DM, Woodford NL, et al. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol 1999; 163: 3653.
24. Carrington CA, Richards AC, Tucker AW, et al. A line oftransgenic pigs in which the expression of human decay-accelerating factor by endothelial cells is increased in the presence of inflammatory stimuli. Xenotransplantation 1996; 3: 87.
25. Bøyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl 1968; 97: 77.
26. Wilson CA, Wong S, Muller J, et al. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998; 72: 3082.
27. Tsang YT, Haskard DO, Robinson MK. Cloning and expression kinetics of porcine vascular cell adhesion molecule. Biochem Biophys Res Commun 1994; 201: 805.
28. Silver J, Maudru T, Fujita K, et al. An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. Nucleic Acids Res 1993; 21: 3593.
29. Lovatt A, Black J, Galbraith D, et al. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. J Virol Methods 1999; 82: 185.
30. Drouet C, Shakhov AN, Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J Immunol 1991; 147: 1694.
31. Darnell JEJ, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415.
32. Cunningham DA, Dunn MJ, Yacoub MH, et al. Local production of cytokines in the human cardiac allograft. A sequential study. Transplantation 1994; 57: 1333.
33. Arbustini E, Grasso M, Diegoli M, et al. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. Am J Pathol 1991; 139: 709.
34. Azzawi M, Grant SD, Hasleton PS, et al. TNF alpha mRNA and protein in cardiac transplant biopsies: comparison with serum TNF alpha levels. Cardiovasc Res 1996; 32: 551.
35. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261.
36. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
37. Byrne GW, McCurry KR, Martin MJ, et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63: 149.
38. Van der Laan LJ, Lockey C, Griffeth BC, et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000; 407: 90.
39. Martin U, Kiessig V, Blusch JH, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692.
40. Tacke SJ, Kurth R, Denner J. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 2000; 268: 87.
41. Langford GA, Galbraith D, Whittam AJ, et al. In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. Transplantation 2001; 72: 1996.
42. Wilson CA, Wong S, VanBrocklin M, et al. Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 2000; 74: 49.
43. Martin U, Winkler ME, Id M, et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000; 7: 138.
44. Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352: 695.
45. Patience C, Patton GS, Takeuchi Y, et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699.
46. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285: 1236.
47. Schumacher JM, Ellias SA, Palmer EP, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 2000; 54: 1042.
48. Pitkin Z, Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 1999; 23: 829.
49. Deng YM, Tuch BE, Rawlinson WD. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 2000; 70: 1010.
50. Martin U, Steinhoff G, Kiessig V, et al. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int 1998; 11: 247.
51. Long Z, Lockey C, Gu ML, et al. Is there cross-species transmission of porcine retroviruses in nonhuman primates transplanted with transgenic pig organs. The 5th Congress of the International Xenotransplantation Association, Nagoya, October 24-28, 1999 (Abstract).
52. Takefman DM, Spear GT, Saifuddin M, et al. Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J Virol 2002; 76: 1999.